Wikipedia:
Febuxostat
| Febuxostat | |
|---|---|
 |
|
| IUPAC name | 2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid |
| Identifiers | |
| CAS number | |
| PubChem | |
| MeSH | |
| Properties | |
| Molecular formula | C16H16N2O3S |
| Molar mass | 316.376 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
Febuxostat is an inhibitor of xanthine oxidase currently under investigation as a potential treatment for gout.[1]
References
- ^ Stamp LK, O'Donnell JL, Chapman PT (2007). "Emerging therapies in the long-term management of hyperuricaemia and gout". Internal medicine journal 37 (4): 258–66. DOI:10.1111/j.1445-5994.2007.01315.x. PMID 17388867.
External links
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
